Hay fever is a type of disease caused by patients being allergic to plant pollen, among which Artemisia pollen has the highest positive rate. Artemisia vulgaris pollen crude extract and one of its main components, Artemisia vulgaris 1 (Art V 1), can induce the occurrence of pollen allergy. Allergy patients mainly present with symptoms of allergic rhinitis and allergic conjunctivitis. Currently, in vitro diagnostics (IVD) methods for Artemisia vulgaris pollen allergy are usually implemented by detecting specific IgE antibodies in the patient's serum.
Main Steps of IVD for Artemisia vulgaris Allergy
Skin prick test. The pollen allergy can be diagnosed using this method, which is simple, safe, and highly sensitive.
The main immunological detection technologies include ImmunoCAP, Western blotting, and ELISA. Allergy can be diagnosed by detecting specific IgE antibodies in the patient's serum.
Creative BioMart provides high-quality recombinant Artemisia vulgaris allergen proteins used for IVD, including ELISA, lateral flow assays, western blots, and other immunoassays.
High purity, no non-specific allergen contamination.
High specificity. The molecular structure and biological activity of recombinant allergens are similar to natural allergens and can effectively stimulate immune responses in allergic patients.
Easy to scale up production. A large number of specific proteins can be obtained through process amplification, without being limited by the content of natural extracts and materials.
Higher safety and repeatability.
Our Outstanding Advantages
Strong technical team, advanced scientific research equipment, and technology that can provide high-quality services.
A rich variety of IVD products to meet the different needs of customers and provide customers with comprehensive scientific research support.
Maintain exceptional service standards with precise and prompt provision of IVD-related services, ensuring an outstanding scientific research experience for our clients.
We lead the IVD industry in developing IVD proteins with superior affinity, specificity, and immunogenicity, tailored to the needs of our customers.
In addition, Creative BioMart also offers a series of allergen proteins and protein-related services to provide customers with high-quality, low-cost active recombinant proteins to meet different needs and assist in preclinical drug development.
Creative BioMart offers a variety of reliable and efficient IVD proteins that provide considerable assistance for medical research and preclinical diagnoses. Moreover, we provide more adaptable and tailored protein services that are suitable for application in IVD reagents, drug development, biotechnology research, and production, as well as other industries. For further information concerning products and services, please do not hesitate to contact us.
Reference
Zhao L, Fu W, Gao B, et al. (2020). Variation in IgE binding potencies of seven Artemisia species depending on content of major allergens[J]. Clinical and Translational Allergy. 10: 1-13.
